+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A randomized prospective comparison of ALG with OKT3 for treatment of renal vascular rejection



A randomized prospective comparison of ALG with OKT3 for treatment of renal vascular rejection



Nephrology Dialysis Transplantation 7(7): 785




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029763282

Download citation: RISBibTeXText


Related references

High or low dose steroid therapy for acute renal transplant rejection after prophylactic Okt3 treatment: a prospective randomized study. Transplant International 5: S437-S439, 1992

High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study. Transplant International 5(Suppl. 1): S437, 1992

A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection. Transplantation 51(1): 180-183, 1991

A prospective comparison of murine monoclonal cd 3 okt3 antibody based and equine antithymocyte globulin based rejection prophylaxis in cardiac transplantation decreased rejection and less corticosteroid use with okt3. Transplantation 47(4): 599-605, 1989

A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3. Transplantation 58(6): 645-649, 1994

Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Transplantation Proceedings 26(1): 273-274, 1994

Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation 50(5): 776-782, 1990

ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial. Transplantation Proceedings 34(6): 2201-2202, 2002

A prospective randomized comparison of okt3 vs alg for cadaver renal transplant recipients with delayed graft function dgf. Journal of Urology 145(4 Suppl.): 345A, 1991

A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection. American Journal of Kidney Diseases 11(2): 86-89, 1988

The risk of infection following Okt3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trial. Transplant International 5: S440-S443, 1992

The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trial. Transplant International 5(Suppl. 1): S440, 1992

Randomized prospective study comparing low-dose OKT3 of low-dose antithymocyte globulins for treatment of the first acute rejection of kidney allografts. Nephrology Dialysis Transplantation 11(6): A276, 1996

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transplant International 11(3): 231-236, 1998

Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation 47(1): 82-88, 1989